Cancer

In one of the first clinical applications of magnetic nanoparticles to reach the market, Endomagnetics has developed a technology that offers a safer, cheaper way to detect whether breast tumours have spread

The advent of personalised medicine means cancer survival over the long term could be improved by running smaller, faster trials with less stringent evidence criteria, the 2011 European Multidisciplinary Cancer Congress in Sweden heard this week